Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Potassium iodide won’t protect you from nuclear reactor radioactive isotopes

Derek Lowe, PhD
Meds
April 6, 2011
Share
Tweet
Share

Well, the nuclear crisis in Japan seems to be causing a run on potassium iodide (KI), and not just in Japan.

If news reports are to be believed, people in many other regions (such as the west coast of the US and Canada) are stocking up, and some of these people may have already started dosing themselves.

Don’t do that. Don’t do it, for several reasons. First, as the chemists and biologists in this site’s readership can tell you, it’s not like KI is some sort of broad-spectrum anti-radiation pill. It can protect people against the effects of radioactive iodine-131, which is a major fission product from uranium. It does that by basically swamping out the radioactive iodine a person might have been exposed to, keeping it from being taken up into the body. Iodine tends to localize in the thyroid gland, and that uptake and local concentration is the real problem. An unfolded newspaper will shield you just fine from the alpha particles that I-131 gives off, but not if it’s giving them off from inside your thyroid. (Correction: I-131 is a beta/gamma emitter – my apologies! The point about not wanting it in your thyroid, of course, stands. . .)

And this is why potassium iodide won’t do a thing to help with the other radioactive isotopes found in nuclear reactors. That includes both the uranium and/or plutonium fuel, as well as the fission products like strontium-90 and radioactive cesium. Strontium-90 is a real problem, since it tends to concentrate in the bones (and teeth), and it has a much longer half-life than I-131. Unfortunately, calcium is so ubiquitous in the body that it’s not feasible to do that uptake-blocking trick the way you can with iodide. The only effective way to deal with strontium-90 is to not get exposed to it.

Another good reason not to take KI pills is that unless you’re actually being exposed to radioactive iodine, it’s not going to do any good at all, and can actually do you harm. Pregnant women and people with thyroid problems, especially, should not go around gulping potassium iodide. Nothing radioactive is reaching North America yet – there’s the Pacific Ocean to dilute things out along the way – which makes it very likely that more people on this side are in the process of injuring themselves by taking large unnecessary doses of iodide. This is like watching people swerve their cars off the road into the trees because they’ve heard that there’s an accident fifty miles ahead.

Now, if I were in Japan and downwind of the Fukushima reactors, I would indeed be taking potassium iodide pills, and doing so while getting the hell out of the area. (That last part, when feasible, is the absolute best protection against radioactive exposure). But here in North America, we’re already the hell out of the area. The only time to take KI pills is when a plume of radioactive iodine is on the way, and that’s not the case over here. We’ll have plenty of notice if anything like that happens, believe me – any event that dumps enough radioactivity to make it to California will be very noticeable indeed. Let’s hope we don’t see anything of the kind – and in the meantime, spare a thought for those reactor technicians who are trying to keep such things from happening. Those people, I hope, will eventually have statues raised to them.

Derek Lowe has worked for several major pharmaceutical companies and blogs at In the Pipeline.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

Caring for people is not always easy, but it is what makes us special

April 5, 2011 Kevin 6
…
Next

Should doctors give more Oxycontin to chronic pain patients?

April 6, 2011 Kevin 26
…

Tagged as: Medications

Post navigation

< Previous Post
Caring for people is not always easy, but it is what makes us special
Next Post >
Should doctors give more Oxycontin to chronic pain patients?

ADVERTISEMENT

More by Derek Lowe, PhD

  • a desk with keyboard and ipad with the kevinmd logo

    The value of new drugs depends on your perspective

    Derek Lowe, PhD
  • a desk with keyboard and ipad with the kevinmd logo

    Bias in top tier academic journals

    Derek Lowe, PhD

More in Meds

  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • Most Popular

  • Past Week

    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
    • How older adults became YouTube’s steadiest viewers and what it means for Alphabet

      Adwait Chafale | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • How older adults became YouTube’s steadiest viewers and what it means for Alphabet

      Adwait Chafale | Conditions
    • The danger of calling medicine a “calling”

      Santoshi Billakota, MD | Physician
    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI on social media fuels body dysmorphia

      STRIPED, Harvard T.H. Chan School of Public Health | Policy
    • Physician work-life balance and family

      Francisco M. Torres, MD | Physician
    • Why hesitation over the HPV vaccine threatens public health and equity

      Ayesha Khan | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
    • How older adults became YouTube’s steadiest viewers and what it means for Alphabet

      Adwait Chafale | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • How older adults became YouTube’s steadiest viewers and what it means for Alphabet

      Adwait Chafale | Conditions
    • The danger of calling medicine a “calling”

      Santoshi Billakota, MD | Physician
    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI on social media fuels body dysmorphia

      STRIPED, Harvard T.H. Chan School of Public Health | Policy
    • Physician work-life balance and family

      Francisco M. Torres, MD | Physician
    • Why hesitation over the HPV vaccine threatens public health and equity

      Ayesha Khan | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Potassium iodide won’t protect you from nuclear reactor radioactive isotopes
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...